ESPE Abstracts (2014) 82 P-D-2-3-509

ESPE2014 Poster Category 2 Perinatal and Neonatal Endocrinology (11 abstracts)

Neonatal Pituiiary–Thyroid Axis Dysregulation with Combined Thyroid Hormone and TSH Resistance in Infant with Trisomy 21 and Maternal Subclinical Hypothyroidism

Astha Soni a , Shivaram Avula b , Mohammed Didi b & Sze May Ng a


aSouthport and Ormskirk Foundation Hospitals NHS Trust, Ormskirk, UK; bAlder Hey Children’s NHS Foundation Trust, Liverpool, UK

Background: Trisomy 21 is associated with dysregulated pituitary thyroid axis with higher TSH and lower FT4 than controls. This may be due to genomic imbalance from trisomy of chromosome 21. Transient congenital hypothyroidism (CH) in newborns is recognised in association with maternal thyroperoxidase (TPO) antibody positivity. ‘Thyroid hormone resistance’ in infancy in CH is also been described.

Objective and hypotheses: We report an interesting case of pituitary thyroid dysregulation with elevated plasma TSH and FT4 in an infant with Trisomy 21.

Method: A term infant with Trisomy 21 was born to a mother with plasma TSH of 7 mU/l, FT4 of 11 pmol/l and TPO positivity during the third trimester. He had FT4 of 23.8 pmol/l and TSH 30.9 mU/l on day 10. TPO antibodies were absent. 99mTc-Pertechnetate scan showed uptake within a bilobed structure in the lower neck. Ultrasound scan showed normal appearance of the thyroid gland. Thyroxine replacement was started at 37.5 μg daily because of high TSH, persistent jaundice and widely open posterior fontanelle consistent with CH. TFT results are shown in Table below. The elevated plasma thyroid hormones failed to normalise plasma TSH.

Results: (Table 1).

Table 1.
Age (days)T4 (11–22 pmol/l)TSH (0.3–5.0 mU/l)FT3 (3.9–6.8 pmol/l)Thyroxine replacement
1628.322.9Started on thyroxine 37.5 μg
2431.26.0Thyroxine reduced to 25 μg
4027.96.57.5Further reduction to 12.5 μg
5022.29.47.2Thyroxine 12.5 μg
6021.110.97.4Same dose as above

Conclusion: The unusual thyroid function and its subsequent behaviour is consistent with combined thyroid hormone and TSH resistance in an infant with Down syndrome and CH.

Article tools

My recent searches

No recent searches.